Healthcare ❯ Pharmaceuticals ❯ Vaccine Development

Clinical Trials

Regulatory Approval FDA Approval MSD Vaccine Regulatory Standards Efficacy and Safety Qdenga Postmarketing Studies Safety and Efficacy Ethics in Research Global Expansion TPOXX

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

Tougher FDA rules are squeezing efforts to test shots in healthy adults 50 to 64.

FDA Weighs Ending Pfizer COVID-19 Authorization for Children Under 5